[go: up one dir, main page]

ES2119581B1 - USE OF FRAGMENTS OF THYMOSINE AND / OR ITS DERIVATIVES - Google Patents

USE OF FRAGMENTS OF THYMOSINE AND / OR ITS DERIVATIVES

Info

Publication number
ES2119581B1
ES2119581B1 ES9301758A ES9301758A ES2119581B1 ES 2119581 B1 ES2119581 B1 ES 2119581B1 ES 9301758 A ES9301758 A ES 9301758A ES 9301758 A ES9301758 A ES 9301758A ES 2119581 B1 ES2119581 B1 ES 2119581B1
Authority
ES
Spain
Prior art keywords
thymosine
fragments
derivatives
reaction
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9301758A
Other languages
Spanish (es)
Other versions
ES2119581A1 (en
Inventor
Prof Christian Birr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ORPEGEN MED MOLEKULARBIOFORSCH
Original Assignee
ORPEGEN MED MOLEKULARBIOFORSCH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ORPEGEN MED MOLEKULARBIOFORSCH filed Critical ORPEGEN MED MOLEKULARBIOFORSCH
Publication of ES2119581A1 publication Critical patent/ES2119581A1/en
Application granted granted Critical
Publication of ES2119581B1 publication Critical patent/ES2119581B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UTILIZACION DE FRAGMENTOS DE TIMOSINA-A1 Y/O SUS DERIVADOS.<- UTILIZACION DE FRAGMENTO Y/O DERIVADO DE TIMOSINA-A1, EVENTUALMENTE EN FORMA DE UNA SAL FARMACOLOGICAMENTE ACEPTABLE, PARA REPARAR UN MEDICAMENTO QUE ACTUA COMO ANTAGONISTA DE LA REACCION INMUNOLOGICA PROVOCADA POR AGENTES ANTITUMORALES.<-USE OF FRAGMENTS OF THYMOSINE-A1 AND / OR ITS DERIVATIVES. <- USE OF FRAGMENT AND / OR DERIVATIVE OF THYMOSINE-A1, EVENTUALLY IN THE FORM OF A PHARMACOLOGICALLY ACCEPTABLE SALT, TO REPAIR A MEDICINAL PRODUCT ACTING AS AN ANTAGONIST OF THE REACTION REACTION ANTITUMORAL AGENTS. <-

ES9301758A 1992-08-05 1993-08-05 USE OF FRAGMENTS OF THYMOSINE AND / OR ITS DERIVATIVES Expired - Fee Related ES2119581B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITTO920683A IT1256925B (en) 1992-08-05 1992-08-05 Use of timosine α 1 fragments and/or derivatives

Publications (2)

Publication Number Publication Date
ES2119581A1 ES2119581A1 (en) 1998-10-01
ES2119581B1 true ES2119581B1 (en) 1999-04-01

Family

ID=11410676

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9301758A Expired - Fee Related ES2119581B1 (en) 1992-08-05 1993-08-05 USE OF FRAGMENTS OF THYMOSINE AND / OR ITS DERIVATIVES

Country Status (2)

Country Link
ES (1) ES2119581B1 (en)
IT (1) IT1256925B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2288118B1 (en) * 2006-05-10 2008-11-01 Bcn Peptides, S.A. PROCEDURE FOR SYNTHESIZING LYMPHOSINS.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4426324A (en) * 1979-09-28 1984-01-17 Hoffmann-La Roche Inc. Immunopotentiating peptides
EP0033384B1 (en) * 1980-01-18 1984-02-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Medicaments containing fragments of thymosin-alpha-1 with immunostimulating activity, and thymosin-alpha-1 fragments
US4374197A (en) * 1980-10-30 1983-02-15 Hoffmann-La Rocche Inc. Process for thymosin α1
EP0056594B1 (en) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1 fragments and pharmaceutical compositions with immunoregulating action containing them
DE3137231A1 (en) * 1981-09-18 1983-04-14 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen BIS-THYMOSINE (ALPHA) (DOWN ARROW) 1 (DOWN ARROW) CONNECTIONS
US4442031A (en) * 1981-10-15 1984-04-10 Hoffmann-La Roche Inc. Immunopotentiating peptides

Also Published As

Publication number Publication date
ITTO920683A0 (en) 1992-08-05
IT1256925B (en) 1995-12-27
ITTO920683A1 (en) 1994-02-05
ES2119581A1 (en) 1998-10-01

Similar Documents

Publication Publication Date Title
MX9700082A (en) Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide.
CO4950529A1 (en) DIHYDROPYRIMIDINES AND PRODUCTS CONTAINING THEM
ES2176684T3 (en) NEW ASSOCIATIONS OF ACTIVE PRINCIPLES CONTAINING CLOPIDOGREL AND AN ANTHROMBOTIC.
ES2181868T3 (en) PHARMACEUTICAL COMPOSITION FOR PIPERIDINOALCANOL COMPOUNDS.
MX9204268A (en) A COMPOSITION FOR THE PROLONGED AND CONTROLLED RELEASE OF MEDICINAL SUBSTANCES AND A PROCESS TO PREPARE THE SAME.
CL2008003938A1 (en) Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00).
GT199800126A (en) COMBINATION THERAPY.
ES2057124T3 (en) THERAPEUTIC PRODUCT FOR THE TREATMENT OF PERI- OR POST-MENOPAUSIC STATES.
ES2182906T3 (en) HELICOIDAL SURGICAL STAPLE.
PT1014961E (en) TREATMENT OF ENXAQUECA ECHUSIA USING METOCLOPRAMIDE AND A NSAID
DK1036058T3 (en) adamantane
DK1036059T3 (en) adamantane
TR199800077T1 (en) Controlled release paroxetine preparations.
FI980862A0 (en) Kirala methylphenyloxazolidinones
MX9704037A (en) 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
MX9706957A (en) Composition containing amlodipine, or a salt or felodipine and anace inhibitor.
ES2032955T3 (en) 5-CHLORINE-3- (2-TENOIL) -2-OXINDOL-1-CARBOXAMIDE SODIUM SODIUM SALT.
ES2160680T3 (en) USE OF A SUBSTANCE ANTAGONIST P IN A PHARMACEUTICAL COMPOSITION.
ES2170143T3 (en) COMPOSITIONS THAT INCLUDE HALOFANTRINE IN A SPECIAL FORM.
FR2767526B1 (en) BI-AROMATIC COMPOUNDS LINKED BY A HETEROETHYNYLENE RADICAL AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
ES2105605T3 (en) TAQUIQUININE ANTAGONISTS, THEIR PREPARATION AND USE IN PHARMACEUTICAL FORMULATIONS.
ATE242642T1 (en) COMBINATION THERAPY FOR LYMPHOPROLIFERATIVE DISEASES
ES2119581B1 (en) USE OF FRAGMENTS OF THYMOSINE AND / OR ITS DERIVATIVES
CO4930269A1 (en) PHARMACEUTICAL COMPOSITIONS
ES2186153T3 (en) SULFATE 5-ALFA-PREGNAN-3-BETA-OL-20-ONA FOR THE TREATMENT OF TUMORS AND CNS DISORDERS.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19981001

Kind code of ref document: A1

Effective date: 19981001

FD1A Patent lapsed

Effective date: 20040806